SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Atlas Venture Opportunity Fund I, L.P., a venture capital affiliate,…

Dyne Therapeutics, Inc. · 144 filed Jun 25, 2026 at 17:29 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 25, 2026 at 17:29 ET

Atlas Venture Opportunity Fund I, L.P., a venture capital affiliate, filed a Form 144 indicating intent to sell 5,019 shares of Dyne Therapeutics (DYN) common stock, with an estimated value of approximately $102,036. The shares were acquired via private placement in August 2020. The proposed sale is negligible relative to DYN's $3.6B market cap and appears routine portfolio management by a significant early investor.

  • Reporting owner: Atlas Venture Opportunity Fund I, L.P.
  • Proposed sale: 5,019 shares of DYN common stock
  • Estimated market value: $102,036.27 as of June 25, 2026
  • Shares acquired via private placement on August 7, 2020

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access